Bifogade filer
Kurs & Likviditet
Beskrivning
Land | Danmark |
---|---|
Lista | First North Stockholm |
Sektor | Hälsovård |
Industri | Bioteknik |
Hørsholm, Denmark, April 26, 2021 - ExpreS2ion Biotech Holding AB ("ExpreS2ion" or the "Company") hereby announces that it has appointed Mr. Eske Rygaard-Hjalsted as new Vice President, Business Development. Mr. Rygaard-Hjalsted brings more than 25 years of sales, marketing, and business development experience and will be focused on growing the Company's commercial foothold, both with respect to the development pipeline activities and the contract research services. Mr. Rygaard-Hjalsted will begin his employment on May 1, 2021 and be based out of ExpreS2ion's headquarters in Hørsholm, Denmark.
Mr. Rygaard-Hjalsted (55) joins ExpreS[2]ion with over 25 years of experience in sales, marketing, and business development in the life sciences industry. He joins ExpreS[2]ion from Intomics A/S, where he held the position as Vice President Sales, Marketing and Business Development. He has held previous positions at DAKO/Agilent A/S, Foss Analytical A/S, and other international companies. He has an MSc Molecular Biology degree from the Technical University of Denmark (DTU) from 1991.
ExpreS[2]ion's CEO Bent Frandsen comments:
"It is with great pleasure that Eske is joining ExpreS[2]ion to support our commercial activities. I trust his experience will ensure a wider outreach in our business development efforts."
Certified Adviser
Svensk Kapitalmarknadsgranskning AB
Telefon: +46 11 32 30 732
E-post: ca@skmg.se